Impact of COVID-19 Outbreak on Global Mycoplasma Testing Market Share | Market Synopsis & Forecast – 2027
Autoimmune Disease Diagnostics Market 2021 The global mycoplasma testing is anticipated to have held a market value of USD 514 million in the year 2017 and is expected to grow at a CAGR of 11.6% during the forecast period. Mycoplasma testing used to detect contamination in given biologic sample. Increasing R&D investment and new product launches are expected to drive the growth of market. According to the Center for Drug Evaluation and Research, in 2017, about 46 novel drug approvals were the 22 novel drug approval in 2016. On other hand, the available of alternative traditional method can restrain the market growth over the assessment period. Get a Sample Request @ https://www.marketresearchfuture.com/sample_request/6776 Major Key Players: Some of the prominent players in the global Mycoplasma Testing Market Share are Charles River Laboratories, Inc., Merck KGaA, Lonza Group Ltd, Roche Diagnostics, SGS S.A., American Type Culture Collection, Invivogen, Wuxi Apptec, Promocell